SCHEMBL7876926

SCHEMBL7876926

CC([CH]C(=O)Nc1ccccn1)C(N)=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.53
RAB9A P51151 6/20 0.53
PKM P14618 3/20 0.53
POLB P06746 1/20 0.52
SMN1; SMN2 Q16637 5/20 0.50
LMNA P02545 2/20 0.50
ALDH1A1 P00352 2/20 0.50
GAA P10253 1/20 0.50
DHODH Q02127 1/20 0.48
KMT2A Q03164 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MEN1 O00255 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
PIM1 P11309 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA2B P29275 1/20 0.46
ADORA1 P30542 1/20 0.46
FLT3 P36888 1/20 0.46
PIM3 Q86V86 1/20 0.46
AURKB Q96GD4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7877015 0.85 NPC1 (0.53) NPC1RAB9APKMPOLBSMN1; SMN2
SCHEMBL7876552 0.83 NPC1 (0.50) NPC1RAB9APKMPOLBSMN1; SMN2
SCHEMBL3890654 0.83 GAA (0.49) NPC1RAB9APKMPOLBSMN1; SMN2
SCHEMBL9586718 0.78 NPC1 (0.56) NPC1RAB9APKMPOLBSMN1; SMN2
SCHEMBL9586710 0.78 NPC1 (0.56) NPC1RAB9APKMPOLBSMN1; SMN2
SCHEMBL1147615 0.77 NPC1 (0.63) NPC1RAB9APKMSMN1; SMN2LMNA
SCHEMBL1185009 0.77 NPC1 (0.63) NPC1RAB9APKMPOLBSMN1; SMN2
SCHEMBL9080412 0.77 NPC1 (0.63) NPC1RAB9APKMSMN1; SMN2LMNA
SCHEMBL14381991 0.77 DHODH (0.56) NPC1RAB9APKMPOLBSMN1; SMN2
SCHEMBL1515626 0.76 NPC1 (0.53) NPC1RAB9APKMPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329400-B1 INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS GLAXO WELLCOME INC. 2001-12-11 US disclosed